Item 8.01 Other Events.

On November 18, 2020, AbbVie Inc. issued a press release announcing the expiration and final results of its offers to exchange any and all of its outstanding (i) $30,000,000,000 aggregate principal amount of senior unsecured notes previously issued on November 21, 2019, (ii) $13,251,781,000 aggregate principal amount of senior unsecured notes previously issued on May 14, 2020 and (iii) €2,517,066,000 aggregate principal amount of senior unsecured notes previously issued on May 14, 2020, each issued pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), for an equal principal amount of new notes in a transaction registered under the Securities Act. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein in its entirety.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits



Exhibit
  No.      Exhibit

  99.1       Press Release dated November 18, 2020.
104        The cover page from this Current Report on Form 8-K formatted in Inline
           XBRL (included as Exhibit 101).




                                       2

© Edgar Online, source Glimpses